METHODS OF PRODUCTING HMO BLEND PROFILES WITH LNFP-1 AND 2'-FL AS THE PREDOMINANT COMPOUNDS

    公开(公告)号:US20240327885A1

    公开(公告)日:2024-10-03

    申请号:US18561123

    申请日:2022-05-17

    IPC分类号: C12P19/00 C12N9/10

    摘要: The present disclosure relates to a method for the production of a human milk oligosaccharide (HMO) blend with LNFP-I and 2′-FL as the predominant HMO's, the method comprising the steps of providing a genetically engineered cell, which comprises a heterologous β-1,3-N-acetyl-glucosaminyltransferase protein, a heterologous β-1,3-galactosyltransferase protein, a heterologous α-1,2-fucosyltransferase protein, and expresses functionally the colanic acid gene cluster, comprises a native or heterologous regulatory or episomal element for controlling the expression of the proteins and optionally express a heterologous sugar transporter, and culturing the cell in a suitable cell culture medium to express said proteins and to produce an HMO blend.

    HMO PRODUCTION
    8.
    发明公开
    HMO PRODUCTION 审中-公开

    公开(公告)号:US20230227876A1

    公开(公告)日:2023-07-20

    申请号:US17759273

    申请日:2021-01-22

    申请人: GLYCOM A/S

    IPC分类号: C12P19/00 C07K14/24

    CPC分类号: C12P19/00 C07K14/24

    摘要: The present invention relates to the field of recombinant production of biological molecules in host cells. More particularly it relates to a method for recombinant production of human milk oligosaccharides (HMO) using a genetically modified cell expressing a protein of the major facilitator superfamily (MFS).